Juan Zhang
Nanjing, 210006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Erratum: Anti-VEGFR2-Interferon α Promotes the Infiltration of CD8+ T Cells in Colorectal Cancer by Upregulating the Expression of CCL5.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 03, 2025
Hybrid EMT Phenotype and Cell Membrane Tension Promote Colorectal Cancer Resistance to Ferroptosis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 29, 2024
Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433].
Journal: Acta pharmaceutica Sinica. B
Published: June 03, 2024
A multifunctional antibody fusion protein 57103 targeting CD24, IL-4R, and αvβ3 for treating cancer and regulating the tumor microenvironment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 15, 2024
Anti-VEGFR2-Interferon α Promotes the Infiltration of CD8+ T Cells in Colorectal Cancer by Upregulating the Expression of CCL5.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 21, 2022
Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach.
Journal: Frontiers in pharmacology
Published: September 07, 2022
A Dynamic Nomogram to Identify Patients at High Risk of Poor Outcome in Stroke Patients with Chronic Kidney Disease.
Journal: Clinical interventions in aging
Published: December 14, 2021
Prediction-Driven Decision Support for Patients With Mild Stroke: A Model Based on Machine Learning Algorithms.
Journal: Frontiers in neurology
Published: August 19, 2021
HIST1H2BN induced cell proliferation and EMT phenotype in prostate cancer via NF-κB signal pathway.
Journal: Genes & genomics
Published: June 10, 2021
VEGFR2-targeted antibody fused with IFN α mut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity.
Journal: Acta pharmaceutica Sinica. B
Published: May 24, 2020
Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report.
Journal: OncoTargets and therapy
Published: October 02, 2018
Last Updated: 09/26/2026